NLS PHARMACEUTICS LTD.

Analyst Reco. NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
0.138 ^USD	+1.47%		+0.95%	-76.61%

08/04	Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	CI
03/04	NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Maxim Downgrades NLS Pharmaceutics to Hold From Buy	14/23/14	MT
Maxim Upgrades NLS Pharmaceutics to Buy From Hold, Price Target is $4	08/22/08	MT
Maxim Downgrades NLS Pharmaceutics to Hold From Buy	08/22/08	MT
Laidlaw Starts NLS Pharmaceutics at Buy With $6 Price Target	06/22/06	MT
Alliance Global Initiates Coverage on NLS Pharmaceutics With Buy Rating	05/22/05	MT
NLS PHARMACEUTICS : Brookline Capital Initiates Coverage on NLS Pharmaceutics AG With Buy Rating, $12 Price Target	12/21/12	MT
NLS PHARMACEUTICS : Maxim Initiates Coverage on NLS Pharmaceutics at Buy With $8 Price Target	03/21/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW